Literature DB >> 24570688

Regaining venous access for implantation of a new lead.

Krzysztof Kuśmierski1, Paweł Syska2, Aleksander Maciąg2, Artur Oręziak3, Mariusz Kuśmierczyk1, Andrzej Przybylski1.   

Abstract

INTRODUCTION: Venous occlusion is a relatively common complication of endocardial lead implantation. It may cause a critical problem when implantation of a new lead is needed. Traditional methods result in leaving abandoned leads. The optimal approach seems to be the extraction of the damaged or abandoned lead, regaining venous access and implantation of a new lead. AIM: To assess the efficacy and safety of new lead implantation by the method of lead extraction.
MATERIAL AND METHODS: All transvenous lead extraction procedures (203 patients) between 1 August 2008 and 15 October 2012 were assessed. The analysis included cases with leads implanted for at least 6 months prior to extraction.
RESULTS: Regaining venous access was the main indication for lead extraction in 5 patients (4.9%). The reason for new lead implantation was lead damage (n = 7) and system up-grade to cardiac resynchronization therapy (CRT) (n = 3). In total, 23 leads were extracted (9 defibrillation leads, 12 pacing leads and 2 left ventricular leads). The mean time from the implantation was 92.2 ±43.2 (48-152) months. In all cases Cook mechanical sheaths were applied. The use of the Evolution system was necessary to extract 3 leads. In all cases the new leads were successfully implanted as planned. No serious complications occurred.
CONCLUSIONS: Diagnosis of venous occlusion should not be a contraindication for ipsilateral implantation of the new lead, because the techniques of transvenous lead extraction enable successful regaining of venous access.

Entities:  

Keywords:  lead extraction; lead reimplantation

Year:  2013        PMID: 24570688      PMCID: PMC3915956          DOI: 10.5114/pwki.2013.34025

Source DB:  PubMed          Journal:  Postepy Kardiol Interwencyjnej        ISSN: 1734-9338            Impact factor:   1.426


Introduction

Significant symptoms of venous occlusion or thrombosis in patients with a pacemaker or implantable cardioverter-defibrillator (ICD) are rarely observed in clinical practice. Most frequently, the diagnosis of occlusion is made accidently or during another procedure related to the implanted device, despite the fact that venous occlusion or its significant stenosis occurs in 10-25% of patients and clinical symptoms are present in 1-3% of cases [1, 2]. Prolongation of life and natural disease progression (especially the onset of heart failure) create a necessity to upgrade the existing pacemaker to an ICD or pacemaker/ICD with possibility of resynchronization (cardiac resynchronization therapy – CRT). In these situations it is necessary to insert a new electrode. Unfortunately, damage to the previously implanted electrode is becoming a more common indication for the procedure. Introduction of a new electrode into the venous system may be difficult due to venous occlusion (Figures 1 and 2). In that case of implantation ipsilateral to the previous one the following management strategies are possible:
Fig. 1

Subclavian vein occlusion after previous im - plantation of the CRT-P – venography after introduction of the vascular sheath

Fig. 2

Subclavian vein occlusion after ICD-DR im plantation – venography after introduction of the vascular sheath

Contralateral implantation of a new device (Figure 3).
Fig. 3

DDD type pacemaker implanted on the left side (electrodes are placed in the right atrium and in the right ventricle). During observation it was necessary to install an ICD, which was implanted on the right side due to left subclavian vein occlusion (antero-posterior view)

Contralateral implantation of a new electrode and its percutaneous tunnelization to the previously created pacemaker implantation site (Figure 4).
Fig. 4

CRT-D implanted on the left side. Visible electrodes: atrial, right ventricular (dual-coil type) and left ventricular. Damage to the right ventricular electrode was noted a few years after its implantation. It was impossible to implant a new electrode on the left side due to subclavian vein occlusion. Because of lack of patient's consent for removal of an old electrode, the new one was implanted on the right side and tunnelized subcutaneously to the site of CRT-D implantation

Removal of a damaged or unnecessary lead and restoration of venous access. Subclavian vein occlusion after previous im - plantation of the CRT-P – venography after introduction of the vascular sheath Subclavian vein occlusion after ICD-DR im plantation – venography after introduction of the vascular sheath DDD type pacemaker implanted on the left side (electrodes are placed in the right atrium and in the right ventricle). During observation it was necessary to install an ICD, which was implanted on the right side due to left subclavian vein occlusion (antero-posterior view) CRT-D implanted on the left side. Visible electrodes: atrial, right ventricular (dual-coil type) and left ventricular. Damage to the right ventricular electrode was noted a few years after its implantation. It was impossible to implant a new electrode on the left side due to subclavian vein occlusion. Because of lack of patient's consent for removal of an old electrode, the new one was implanted on the right side and tunnelized subcutaneously to the site of CRT-D implantation The techniques listed in points 1 and 2 are subject to great inconvenience and potential risk of late complications resulting from the interaction between two implanted electronic devices, excess of remaining electrodes in the venous system and the need for creation of a percutaneous passage of electrodes. Therefore, the optimal procedure seems to consist of removal of the unnecessary electrode by means of special sets and, obtained this way, restoration of venous access.

Aim

The aim of the study was to assess the efficacy and safety of a new electrode implantation technique consisting of electrode removal and restoration of venous access.

Material and methods

The analysis included procedures of endocavitary electrode removal by means of transvenous technique performed between 1.08.2008 and 15.10.2012. Only the removal procedures for electrodes implanted ≥ 6 months earlier were chosen. Of the database including 203 patients, only procedures in which the main indication for removal was the need for implantation of a new electrode in spite of an existing ipsilateral venous occlusion were taken into consideration.

Procedure description

The procedures were performed in the operating theatre (and from January 2012 in a hybrid catheterization laboratory) with a possibility of immediate sternotomy and surgery with the use of extracorporeal circulation. Intratracheal general anaesthesia was used. There was continuous ECG, blood pressure, central venous pressure and oxygen saturation monitoring during the whole procedure. All elements of the procedures involving manoeuvres in the cardiovascular system were performed under fluoroscopy [3, 4]. Electrodes were dissected by means of an electric knife and their lumen was engaged with a standard guidewire. An attempt to unscrew the fixing element in case of active fixation electrodes was performed under fluoroscopy. If it was possible to use manual traction, an electrode stabilized with a guidewire covered with long sheath from the electrode extraction set was used. In all other cases a countertraction technique was applied. It is based on the use of a locking stylet (Liberator, COOK) and telescope Teflon or polypropylene sheaths (7-16 F). In case of failure to release the electrode from its adhesions, especially on its course in the subclavian or innominate vein, with the use of Teflon or polypropylene sheaths, mechanical traction by means of the COOK evolution set was applied. This technique was described in detail previously [5-8]. After removal of an unnecessary electrode the remaining sheath from the electrode extraction set was used to introduce a hemodynamic guidewire (0.8 mm, 150 cm length) into the right atrium. In situations where implantation of more than 1 electrode was needed an adequate number of guidewires was introduced. After removal of the extraction sheath the introduced guidewires were covered in a typical way with vascular peel-away sheaths (8-10 F, depending on the type of electrode). They were subsequently used to introduce new electrodes into the venous system. Electrodes were implanted according to the current standards with radiological control of their position and measurement of electrophysiological parameters. Then electrodes were connected to the device, which was placed in the implantation site. The wound was sutured in layers. After the procedure patients remained under observation in the intensive care unit. All procedures of electrode extraction were followed by echocardiographic and radiological (exclusion of pulmonary emphysema) examination.

Statistical analysis

Continuous variables were presented as arithmetic means ± standard deviations (SD) and categorical variables were depicted as percentages (%).

Results

During the analysed period a necessity to restore the vascular access was the main indication for the procedure in 10 patients (4.9%). The need for implantation of a new electrode was related to: (1) electrode damage – 7 patients; (2) system upgrade (the use of resynchronization therapy) – 3 patients. Patients’ clinical characteristics are presented in Table 1. Mean age of the patients was 59.5 ±21.4 years (14-80 years). In 5 patients only one electrode was removed. In 5 other cases it was necessary to extract more than 1 electrode. This was caused by malfunction of another electrode (n = 2), presence of the pacemaker on the other side of the body (n = 1), and dislocation or damage of an electrode during the procedure (n = 2). Altogether, 23 electrodes were extracted (9 defibrillation electrodes, 12 pacing electrodes and 2 left ventricular electrodes). Mean time from their implantation was 92.2 ±42.21 months (48-152 months). In the case of 20 electrodes, Teflon or polypropylene sheaths were used. Additional application of the Evolution system (except telescopic sheaths) was necessary for the extraction of three electrodes [4]. Manual traction (after previous extraction of a different electrode and restoration of venous access by means of telescopic sheaths) was enough for removal of three electrodes. Previously implanted, correctly functioning atrial electrodes were left in two cases. Detailed data presenting types of extracted electrodes, their age and the applied technique are presented in Table 2. In all cases it was possible to implant new electrodes as pre-planned. There were no serious complications in the analysed group (death, need for surgical intervention, pulmonary embolism, complications of anaesthesia, stroke or systemic infection).
Table 1

Clinical characteristics of patients

PatientAge [years]SexDiagnosisNYHA classPresent deviceNew deviceThe number of extracted leads
174MDCMII/IIICRT-PCRT-P1
262FDCMIIIICD-VR (right side), DDD (left side)CRT-D3
314MLQTSIICD-DRICD-DR2
468FTBSIIDDDDDD2
523FLQTSIICD-VRICD-VR2
661FDCMIIICRT-DCRT-D3
778MICMIIICRT-DCRT-D4
880MICMIIIICD-VRICD-VR2
965FHCMIIDDDDDD2
1070MCADIIIICD-DRCRT-D2

M – male, F – female, DCM – dilated cardiomyopathy, LQTS – long QT syndrome, TBS – tachycardia-bradycardia syndrome, ICM – ischemic cardiomyopathy, HCM – hypertrophic cardiomyopathy

M – mężczyzna, F – kobieta, DCM – kardiomiopatia rozstrzeniowa, LQTS – zespół wydłużonego QT, TBS – zespół tachycardia-bradykardia, ICM – kardiomiopatia niedokrwienna, HCM – kardiomiopatia przerostowa

Table 2

Data regarding the type of extracted electrodes and the extraction technique

Elect-rodeAge of the electrode [months]A/RV/LVFixation typeTraction typeMechanical sheathLocking stylet guidewire (Liberator)Mechanical sheath with rotational tip (Evolution)Complete/partial removalTime of fluoro-scopy [min]
197RVActiveMechanical100Complete4
2152APassiveMechanical110Complete10
3152RVPassiveMechanical110Complete10
446RV (ICD, two coils)ActiveMechanical110Complete4
548AActiveMechanical110Complete10
648RV (ICD, two coils)ActiveMechanical111Partial (7 cm left)50
760APassiveMechanical111Complete15.5
860RVPassiveManual000Complete0.5
975RV (ICD, single coil)ActiveMechanical110Complete7.5
1051RV (ICD, two coils)PassiveMechanical110Complete10
1157AActiveManual000Complete5
1257RV (ICD, two coils)ActiveMechanical110Complete10
1357LVPassiveMechanical100Complete7
1488APassiveMechanical110Complete8
1588RVPassiveMechanical110Complete5
1669RV (ICD, two coils)ActiveMechanical100Complete10
1769LVPassiveMechanical100Complete2
18144RV (ICD, single coil)PassiveMechanical100Complete8
1983RV (ICD, single coil)ActiveMechanical110Complete12
20164APassiveMechanical110Complete10
21164RVPassiveMechanical111Complete25
22146RV (ICD single coil)PassiveMechanical110Complete10
23146RAActiveMechanical110Complete3

A – atrial, RV – right ventricular, LV – left ventricular, ICD – implantable cardioverter-defibrillator

A – elektroda przedsionkowa, RV – elektroda prawokomorowa, LV – elektroda lewokomorowa, ICD – implantowany kardiowerter-defibrylator

Clinical characteristics of patients M – male, F – female, DCM – dilated cardiomyopathy, LQTS – long QT syndrome, TBS – tachycardia-bradycardia syndrome, ICM – ischemic cardiomyopathy, HCM – hypertrophic cardiomyopathy M – mężczyzna, F – kobieta, DCM – kardiomiopatia rozstrzeniowa, LQTS – zespół wydłużonego QT, TBS – zespół tachycardia-bradykardia, ICM – kardiomiopatia niedokrwienna, HCM – kardiomiopatia przerostowa Data regarding the type of extracted electrodes and the extraction technique A – atrial, RV – right ventricular, LV – left ventricular, ICD – implantable cardioverter-defibrillator A – elektroda przedsionkowa, RV – elektroda prawokomorowa, LV – elektroda lewokomorowa, ICD – implantowany kardiowerter-defibrylator

Discussion

The study presented the management technique in case of venous occlusion in patients with previously implanted pacing or defibrillating electrodes, who require implantation of a new electrode. According to the current guidelines of the cardiological societies, class I indications for electrode extraction include bilateral subclavian vein or superior vena cava thrombosis in patients who require implantation of a new electrode. Class I indications also include situations when contralateral implantation is contraindicated (for example in patients after mastectomy or with the presence of a dialysis fistula). Restoration of venous access, if contralateral implantation is possible, was given a class II indication [3, 4]. There are not many studies on this subject in the literature [9-11]. It is difficult to assess in which percent of cases venous occlusion was the main indication for extraction of a previously implanted electrode. It is also impossible to find out how often alternative strategies are used (contralateral implantation or electrode tunnelization). There are also no data on the frequency of the use of other techniques for the system upgrade (for example, sewing of the left ventricular electrode with cardio-surgical methods) or how frequently the idea of system upgrade or the use of resynchronization therapy is abandoned. Venous occlusion is relatively frequent in patients with implanted endocavitary electrodes [1]. It is assumed that various degrees of stenosis are present in about 30% of patients. Due to asymptomatic course the diagnosis is made during system upgrade or removal of the damaged electrode. This has significant practical implications: venous patency on the side of the planned implantation should also be assessed before the procedure. Examinations shown to adequately assess the status of the venous system include venography and computed tomography. Ultrasonography does not permit one to assess the patency of the innominate vein or superior vena cava. It is important to remember that contrast administration through the antecubital vein may not demonstrate stenosis or occlusion of the superior vena cava. One of the methods of assessment consists of subclavian vein puncture and an attempt to introduce a 0.32-0.35 F guidewire to the right atrium (before preparation of the implantation site). Continuation of the procedure depends on the possibility to overcome the eventual occlusion and to introduce the guidewire beyond the occlusion site. Detection of the venous occlusion permits one to avoid unnecessary preparation of the implantation site, which is related to patient discomfort and increased risk of infection. It also allows one to plan another management strategy. Several laser techniques used to remove old electrodes and regain venous access have been described in the literature [9]. It was possible to restore venous access for implantation of new electrodes in all cases of 18 patients undergoing this type of procedure. An interesting, but rather controversial technique was described by Staniforth and Schilling [11]. It is based on removal of metallic parts of the electrode from the isolation followed by the introduction of a hemodynamic guidewire inside the isolation and electrode removal through the femoral vein. The guidewire remains in the right atrium, which permits the installation of a new sheath and electrode introduction. It should be noted that in almost 10% of cases (a total of 34 patients) it was impossible to fully remove the electrode. Released electrodes left in the vascular system are a source of potential complications related to electrode migration, arrhythmia generation or pulmonary embolism. In conclusion, it should be noted that implantation of a new electrode on the side of the previously installed device is possible despite venous occlusion. It should be expected that the number of patients with indications for this type of procedure will continue to grow. Such treatment, however, should be carried out with full cardio-surgical support, as the risk of serious complications associated with removal of the electrodes is 2-3%. It should also be noted that venous access restored after removal of the electrode is usually not permanent and that clinical signs of venous thrombosis occur quite often, which may be associated with endothelial damage in a large portion of the vein and with closure of collateral circulation [12].

Conclusions

The presence of venous occlusion should not be regarded as a contraindication to an upgrade of the existing system or to implantation of new electrodes on the side of the previously implanted device. Transvenous techniques of electrode removal permit venous access to be restored.
  10 in total

1.  Symptomatic occlusion of the access vein after pacemaker or ICD lead extraction.

Authors:  F A Bracke; A Meijer; L M Van Gelder
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

2.  [Necessity of endocardial lead removal in device upgrade in a patient with left subclavian vein occlusion - a case report].

Authors:  Barbara Małecka; Andrzej Zabek; Andrzej Kutarski; Andrzej Maziarz; Jacek Lelakowski
Journal:  Kardiol Pol       Date:  2009-04       Impact factor: 3.108

3.  Percutaneous extraction of endocardial leads--a single centre experience in 120 patients.

Authors:  Andrzej Kutarski; Barbara Małecka; Piotr Ruciński; Andrzej Zabek
Journal:  Kardiol Pol       Date:  2009-02       Impact factor: 3.108

4.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

5.  Central venous occlusion is not an obstacle to device upgrade with the assistance of laser extraction.

Authors:  Lorne J Gula; Alyson Ames; Ashley Woodburn; John Matkins; Michael McCormick; Jeffrey Bell; Deborah Sink; James McConville; Laurence M Epstein
Journal:  Pacing Clin Electrophysiol       Date:  2005-07       Impact factor: 1.976

6.  Reuse of occluded veins during permanent pacemaker lead extraction: a new indication for femoral lead extraction.

Authors:  Andrew D Staniforth; Richard J Schilling
Journal:  Indian Pacing Electrophysiol J       Date:  2002-10-01

Review 7.  Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.

Authors:  Grzegorz Rozmus; James P Daubert; David T Huang; Spencer Rosero; Burr Hall; Charles Francis
Journal:  J Interv Card Electrophysiol       Date:  2005-06       Impact factor: 1.900

8.  Venous occlusion of the access vein in patients referred for lead extraction: influence of patient and lead characteristics.

Authors:  Frank Bracke; Albert Meijer; Berry Van Gelder
Journal:  Pacing Clin Electrophysiol       Date:  2003-08       Impact factor: 1.976

9.  Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads.

Authors:  Maria Grazia Bongiorni; Ezio Soldati; Giulio Zucchelli; Andrea Di Cori; Luca Segreti; Raffaele De Lucia; Gianluca Solarino; Alberto Balbarini; Mario Marzilli; Mario Mariani
Journal:  Eur Heart J       Date:  2008-10-23       Impact factor: 29.983

10.  A single-centre experience of over one thousand lead extractions.

Authors:  Charles Kennergren; Christian Bjurman; Roger Wiklund; Jakob Gäbel
Journal:  Europace       Date:  2009-03-27       Impact factor: 5.214

  10 in total
  1 in total

1.  One step behind to step ahead - femoral approach to stabilize and to extract functional pacing lead to regain venous access.

Authors:  Aleksander Maciąg; Paweł Syska; Krzysztof Kuśmierski; Beata Broy; Maciej Sterliński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.